Calcium-mediated myopathy at neuromuscular junctions of normal and dystrophic muscle

IMPROVEMENTS IN EPOXY RESIN EMBEDDING METHODS

1961 • 10,270 citations

Lysosomes in biology and pathology

1977 • 2,068 citations

Lysosomotropic agents

1974 • 1,887 citations

Calcium Dependence of Toxic Cell Death: A Final Common Pathway

1979 • 1,478 citations

Proteases and biological control

1976 • 1,380 citations

Method for the Quantitative Morphologic Analysis of Tissues

1943 • 979 citations

A Modified Method for Lead Staining of Thin Sections

1968 • 816 citations

Inhibition of the Lysosomal Pathway of Protein Degradation in Isolated Rat Hepatocytes by Ammonia, Methylamine, Chloroquine and Leupeptin

1979 • 466 citations

[55] Structures and activities of protease inhibitors of microbial origin

1976 • 445 citations

A Ca²⁺ion-activated protease possibly involved in myofibrillar protein turnover. Purification from porcine muscle

1976 • 413 citations

Proteases and biological control

1975 • 412 citations

A calcium(2+) ion-activated protease possibly involved in myofibrillar protein turnover. Partial characterization of the purified enzyme

1976 • 395 citations

Intracellular calcium accumulation in Duchenne dystrophy and other myopathies

1978 • 385 citations

Ca2+-SPECIFIC REMOVAL OF Z LINES FROM RABBIT SKELETAL MUSCLE

1972 • 374 citations

Removal of Z-lines and alpha-actinin from isolated myofibrils by a calcium-activated neutral protease

1975 • 268 citations

Leupeptin, a Protease Inhibitor, Decreases Protein Degradation in Normal and Diseased Muscles

1978 • 267 citations

Agonist-induced myopathy at the neuromuscular junction is mediated by calcium.

1979 • 242 citations

Selective Destruction of Neurons by a Transmitter Agonist

1977 • 193 citations

Development and Neurobiology of Drosophila

1980 • 190 citations

Carbamylation of Acetylcholinesterase

1960 • 176 citations

Muscular Dystrophy: Inhibition of Degeneration in Vivo with Protease Inhibitors

1978 • 151 citations

Study of long‐term anticholinesterase therapy

1973 • 142 citations

Inhibition of proteolytic activity of calcium activated neutral protease by leupeptin and antipain

1978 • 130 citations

CHANGES IN MUSCLE STRUCTURE IN DYSTROPHIC PATIENTS, CARRIERS AND NORMAL SIBLINGS SEEN BY ELECTRON MICROSCOPY; CORRELATION WITH LEVELS OF SERUM CREATINEPHOSPHOKINASE (CPK)*

1966 • 128 citations

Differential effects of proteinase inhibitors and amines on the lysosomal and non-lysosomal pathways of protein degradation in isolated rat hepatocytes

1980 • 114 citations

Reversible necrosis at the end-plate region in striated muscles of the rat poisoned with cholinesterase inhibitors

1969 • 107 citations

Biochemical Abnormalities of the Sarcoplasmic Reticulum in Muscular Dystrophy

1969 • 99 citations

Chronic inhibition of cholinesterase as a cause of myopathy

1972 • 98 citations

Delayed degeneration of dystrophic and normal muscle cell cultures treated with pepstatin, leupeptin, and antipain

1976 • 97 citations

Calcium-Activated Neutral Protease: Its Localization in the Myofibril, Especially at the Z-Band1

1980 • 90 citations

Ultrastructural changes at the motor end-plate produced by an irreversible cholinesterase inhibitor

1975 • 90 citations

Endplates after esterase inactivationin vivo: correlation between esterase concentration, functional response and fine structure

1979 • 80 citations

Relationship between acetylcholinesterase inhibition and the development of a myopathy.

1978 • 70 citations

Inhibition of lysosomal function in red and white skeletal muscles by chloroquine

1981 • 68 citations

Ca‐activated neutral protease and its inhibitors: In vitro effect on intact myofibrils

1980 • 63 citations

Muscular dystrophy and other myopathies: sarcotubular vesicles in early disease

1969 • 62 citations

Sarcoplasmic Reticulum in Duchenne Muscular Dystrophy

1973 • 61 citations

Initial ultrastructural abnormalities at the motor end plate produced by a cholinesterase inhibitor

1977 • 61 citations

Skeletal muscle lysosomes.

1975 • 59 citations

Paraoxon-induced myopathy: Muscle specificity and acetylcholine involvement

1976 • 57 citations

Neostigmine-induced alterations at the mammalian neuromuscular junction. II. Ultrastructure.

1978 • 56 citations

Pathogenesis of Human Muscular Dystrophy

1978 • 48 citations

Increased calcium-activated neutral protease activity in muscles of dystrophic hamsters and mice

1979 • 45 citations

Die Ultrastruktur der motorischen Endplatte im Zwerchfell der Ratte und Ver�nderungen nach Inhibierung der Acetylcholinesterase

1967 • 39 citations

The effect of acetylcholine on the function and structure of the developing mammalian neuromuscular junction

1980 • 38 citations

An experimental myopathy secondary to excessive acetylcholine release

1974 • 38 citations

Reduction of protein degradation and atrophy in cultured fetal mouse hearts by leupeptin.

1979 • 32 citations

Skeletal muscle lysosomes.

1975 • 28 citations

The Pharmacology of Experimental Myopathies

1977 • 26 citations

Therapeutic Trials in Muscular Dystrophy

1977 • 22 citations

Ultrastructural Reactions in Muscle Disease

1968 • 18 citations

Failure to protect frog skeletal muscle from ionophore-induced damage by the use of the protease inhibitor leupeptin

1979 • 17 citations

Inhibierung und Restitution der Azetylcholinesterase an der motorischen Endplatte im Zwerchfell der Ratte nach Intoxikation mit Soman

1968 • 14 citations

Higher Behavior in Drosophila Analyzed with Mutations that Disrupt the Structure and Function of the Nervous System

1980 • 13 citations

Die Azetylcholinesterase an der motorischen Endplatte des Rattenzwerchfells nach Intoxikation mit Paraoxon und Soman bei Applikation von Oximen

1970 • 10 citations

Deleted Work

1955 • 0 citations